Rocket Pharmaceuticals, Inc. (RCKT) Discusses FDA Approval of KRESLADI Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1 Transcript

Corroborated by 1 source from 1 publisher

ushealth1d ago

TL;DR

According to seekingalpha.com, rocket Pharmaceuticals, Inc.

Sources

1

Seeking Alpha Market News

https://seekingalpha.com/article/4886599-rocket-pharmaceuticals-inc-rckt-discusses-fda-approval-of-kresladi-gene-therapy-for-severe?source=feed_all_articles

1d ago